IRVINE, Calif. & BASEL, Switzerland–(BUSINESS WIRE)–Urovant Sciences Announces Progression of URO-902 Phase 2a Trial Following Positive Recommendation from the DSMB
IRVINE, Calif. & BASEL, Switzerland–(BUSINESS WIRE)–Urovant Sciences Announces Progression of URO-902 Phase 2a Trial Following Positive Recommendation from the DSMB
Copyright © 2023 Biotech Networks, LLC